欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2021, Vol. 26 ›› Issue (2): 204-212.doi: 10.12092/j.issn.1009-2501.2021.02.012

• 综述与讲座 • 上一篇    下一篇

噻嗪类利尿剂相关不良反应的药物基因组学研究进展

邢 开1,2,龚金玉1,2,罗建权1,2   

  1. 1中南大学湘雅二医院药学部,长沙 410011,湖南;2中南大学临床药学研究所,长沙 410011,湖南
  • 收稿日期:2020-07-20 修回日期:2020-09-11 出版日期:2021-02-26 发布日期:2021-03-04
  • 通讯作者: 罗建权,男,博士,临床药师,硕士生导师,研究方向:心血管病药物基因组学与个体化用药。 Tel: 0731-85292074 E-mail: Luojianquanxy@csu.edu.cn
  • 作者简介:邢开,男,硕士,研究方向:心血管病药物基因组学与个体化用药。 Tel: 19976670312 E-mail: xingkaii@163.com
  • 基金资助:
    国家自然科学基金项目(81703623);湖南省科学基金项目(2018553719);吴阶平医学基金(320.6750.2020-04-14)

Advances on pharmacogenomics of diuretics-related adverse reactions

XING Kai 1,2, GONG Jinyu 1,2, LUO Jianquan 1,2   

  1. 1 Department of Pharmacy, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China; 2 Institute of Clinical Pharmacy, Central South University, Changsha 410011, Hunan, China
  • Received:2020-07-20 Revised:2020-09-11 Online:2021-02-26 Published:2021-03-04

摘要: 利尿剂是治疗高血压的一线药物。长期使用利尿剂会导致血糖升高、电解质紊乱(最常见的是低钾血症)、脂代谢异常(如甘油三脂、胆固醇升高)、血尿酸水平升高等。为了明确常用利尿剂治疗高血压引起相关不良反应的具体机制,大量文献报道了利尿剂相关不良反应的药物基因组学研究。本综述讨论了常用利尿剂治疗高血压引起不良反应的相关基因及其变异,以期为利尿剂的个体化治疗研究提供依据。

关键词: 利尿剂, 高血压, 不良反应, 药物基因组学

Abstract: Diuretics are the first-line drugs for the treatment of hypertension. Long-term use of diuretics often causes elevated blood sugar, electrolyte disturbances (most commonly hypokalemia), abnormal lipid metabolism (such as increased triglycerides, elevated cholesterol), increased serum uric acid levels and so on. In order to clarify the specific mechanism of the adverse reactions related to diuretics which are widely used in the treatment of hypertension, many documents have reported the pharmacogenomics research of diuretics-related adverse reactions. This review discusses the related genes and their variants of adverse reactions caused by commonly used diuretics in the treatment of hypertension in hope of providing a basis for the study of individualized use of diuretics.

Key words: diuretics, hypertension, adverse reactions, pharmacogenomics

中图分类号: